14 Best ARK Stocks To Buy Now
In this article, we discuss the 14 best ARK stocks to buy now.
Intellia Therapeutics Inc. (NTLA)
Market is closed
News
- First
- << Previous
- 31 - 40
- Next >>
10 Best Biotech Stocks To Buy According To Hedge Funds
In 2023, digitalization will increase in the biotech industry as the possibility of online and remote assessment, diagnosis, and treatment of patients around the world heightens.
5 Most Promising Gene Therapy Companies to Watch
Krystal Biotech, Inc. (NASDAQ:KRYS)'s latest quarter saw the firm beat analyst estimates, as it posted -$0.17 in earnings per share for its third fiscal quarter.
5 Biggest Genomics Companies In The World
In this article, we will discuss the 5 Biggest Genomics Companies In The World.
ARK Invest Stock Portfolio: Top 10 Picks
ARK Investment Management’s Cathie Wood wrote an open letter to the central bank on October 10, saying that the Federal Reserve is mistaken in its aggressive stance against inflation.
5 Best Gene Editing Stocks To Buy
Graphite Bio, Inc. (NASDAQ:GRPH) is a clinical-stage gene editing company based in San Francisco, California. It develops therapies for life-threatening diseases in the United States.
Cathie Wood is Buying These 10 Stocks in September
In this article, we discuss 10 stocks that Cathie Wood is buying in September.
Top 12 From Cathie Wood's Q2 Portfolio
In this article, we will be taking a look at the top 12 from Cathie Wood's Q2 portfolio.
Cathie Wood Dumped These 3 Stocks in July
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a Massachusetts-based genome editing company that develops novel genomic medicines using CRISPR/Cas9 technology for the treatment of ocular diseases.
Cathie Wood is Not Letting Go of These 5 Stocks Despite Losses
In this article, we discuss 5 stocks that Cathie Wood is not letting go of despite losses.
- First
- << Previous
- 31 - 40
- Next >>
Billionaire Hedge Funds
